Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs. In response to advocacy and litigation, many states have reduced or eliminated their restrictions, but significant barriers remain in a majority of jurisdictions.
Join us on March 21 for our latest snapshot of the national HCV treatment landscape and our team’s insights into the road that lies ahead.
Register here: https://zoom.us/meeting/register/tJctdO6rqDkrHd0zrfV1lwH7JoUDLJkfzXik?#/registration